Pēdējā atjaunošana :
19/11/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Penicillin G sodium
Ķīmiskā uzbūve
Oriģinālais nosaukums
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
Benapen
Brazīlija
Bencilpenicilina
Čīle, Ekvadora, Peru
Benpen
Austrālija, Jaunzēlande
Bensylpenicillin
Zviedrija
Benzapen
Irāna
Benzatec
Dienvidāfrikas Republika
Benzatron
Brazīlija
Benzylpenicillin
Dānija, Ēģipte, Norvēģija, Somija, Zviedrija
Benzylpenicilline
Tunisija
Biconcillina
Ekvadora
Crystapen
Īrija, Kanāda, Lielbritānija
Declin
Meksika
Fortepen
Saūda Arābija
Geepenil
Somija
Natrium penicillin G
Holande
Novopen
Dienvidāfrikas Republika
Pebencil
Venecuēla
Penbendox
Meksika
Penibiot
Spānija
Penicillin
Norvēģija
Penicillina G sodica
Argentīna, Čīle, Ekvadora, Kolumbija, Portugāle
Penilevel
Spānija
Sodiopen
Spānija
Unicillina
Spānija
Literatūras saraksts : Penicillin G sodium
tips
publicēšana
13
Žurnāls
Stiles ML, Allen LV.
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440
Žurnāls
Stiles ML, Tu YH, Allen LV.
Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057
Žurnāls
Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072
Žurnāls
Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241
Žurnāls
Rayani S, Jamali F.
The stability of penicillin G sodium in 5% dextrose in water minibags after freezing.
Can J Hosp Pharm 1985 ; 38: 162-163.
1263
Žurnāls
Allwood MC, Brown PW.
The effect of buffering on the stability of reconstituted benzylpenicillin injection.
Int J Pharm Pract 1992 ; 1: 242-244.
1725
Žurnāls
Oliver C, Law S.
Compatibility of oxytocin, zidovudine, and penicillin G.
Can J Hosp Pharm 2001 ; 54: 112-113.
2056
Žurnāls
Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.
Stability of benzylpenicillin during continuous home intravenous therapy.
J Antimicrob Chemother 2004 ; 53: 675-677.
2087
Žurnāls
Ferreira E, Forest JM, Hildgen P.
Compatibility of dimenhydrinate injectable by Y administration.
Pharmactuel 2004 ; 37: 17-20.
2090
Žurnāls
Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
3012
Žurnāls
Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3227
Žurnāls
Simon B, Hancu G, Gy?resi A.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520
Laboratorija
Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529
Laboratorija
Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3540
Laboratorija
Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3549
Laboratorija
Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3580
Laboratorija
Cytarabine Accord - Résumé des caractéristiques du produit
Accord Healthcare France 2016
3585
Laboratorija
Benzylpenicillin sodium - Summary of Product Characteristics
Genus Pharmaceuticals 2008
3643
Laboratorija
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3648
Žurnāls
Hossain M.A, Friciu M, Aubin S, Leclair G.
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.
Am J Health-Syst Pharm 2014 ; 71:669-673.
3674
Laboratorija
Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3702
Žurnāls
McDougall D.A.J, McWhinney.
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931
Laboratorija
Trimébutine (Débridat®) - Résumé des caractéristiques du produit
Pfizer Laboratoire 2016
3964
Žurnāls
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
4154
Laboratorija
Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4319
Žurnāls
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4389
Žurnāls
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4590
Žurnāls
Smith E.K, McWhinney MPhil B.C.
Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service.
J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603
Žurnāls
Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4831
Žurnāls
Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I.
Frequently acquired drugs in neonatal intensive care and their physical compatibility.
Acta Paediatr 2022 ;111:2307–2314.
4837
Žurnāls
De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.
Mentions Légales